Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · IEX Real-Time Price · USD
1.280
+0.080 (6.67%)
At close: Jul 2, 2024, 4:00 PM
1.270
-0.010 (-0.78%)
After-hours: Jul 2, 2024, 7:59 PM EDT
PACB's stock price has decreased by -90.07% in the past year and price targets may not have had time to catch up.
PACB Analyst Ratings
Total Analysts
15
Consensus Rating
Buy
Price Target
$6.59
Upside
+414.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jun 3, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $4 | Hold | Maintains | $10 → $4 | +212.50% | May 15, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $6.5 → $2 | Hold | Maintains | $6.5 → $2 | +56.25% | May 13, 2024 |
| Barclays | Barclays | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | +56.25% | May 10, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 22, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $7 → $2.5 | Hold | Maintains | $7 → $2.5 | +95.31% | Apr 19, 2024 |
| Bernstein | Bernstein | Buy Maintains $9 → $2.5 | Buy | Maintains | $9 → $2.5 | +95.31% | Apr 18, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $7 → $2.5 | Strong Buy → Hold | Downgrades | $7 → $2.5 | +95.31% | Apr 18, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $15 → $8 | Buy | Maintains | $15 → $8 | +525.00% | Apr 18, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $12 → $2.5 | Strong Buy | Maintains | $12 → $2.5 | +95.31% | Apr 17, 2024 |
| Barclays | Barclays | Hold Maintains $8 → $3 | Hold | Maintains | $8 → $3 | +134.38% | Apr 10, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +446.88% | Apr 10, 2024 |
| UBS | UBS | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +837.50% | Feb 16, 2024 |
| Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Dec 14, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $11 | Buy | Initiates | $11 | +759.38% | Dec 14, 2023 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Dec 13, 2023 |
| UBS | UBS | Hold → Strong Buy Upgrades $13 → $10 | Hold → Strong Buy | Upgrades | $13 → $10 | +681.25% | Nov 17, 2023 |
| Piper Sandler | Piper Sandler | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +525.00% | Nov 6, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +1,071.88% | Oct 31, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold → Buy Upgrades $14 → $11 | Hold → Buy | Upgrades | $14 → $11 | +759.38% | Oct 31, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $13 → $10 | Hold | Maintains | $13 → $10 | +681.25% | Oct 24, 2023 |